EP4647106A1 — Intraurethral administration device and kit
Assigned to Instituto Galzu Pesquisa Ensino Ciencia E Tecnologia Aplicada · Expires 2025-11-12 · 1y expired
What this patent protects
Intraurethral administration of medications is a practice known for rapid absorption, reduced side effects and the toxicity, in addition to reduce the pharmaceutical formulations dose. Present invention aims ergonomics and comfort for using urethral device administration of liqui…
USPTO Abstract
Intraurethral administration of medications is a practice known for rapid absorption, reduced side effects and the toxicity, in addition to reduce the pharmaceutical formulations dose. Present invention aims ergonomics and comfort for using urethral device administration of liquid or gel medication directly into the man's urethral channel. More specifically, the device comprises a housing with domed shape associated to a non-standard syringe increased volumetric capacity and extended nozzle, plunger lock, cover and kit for accommodate the small intraurethral applicator. The present invention belongs to the fields of Pharmacy and Medicine and among the various applications, special emphasis is placed on erectile dysfunction, but this urethral route can also be used to variety of pharmaceutical formulations as: anti-inflammatories, antiseptics, antibiotics, anesthetics, among other applications with different color device, allowing the use both by the patient (self-administration) and by the healthcare professional.
Drugs covered by this patent
- Epipen (epinephrine) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.